MedPath

To study the effect of Pradarahara Kasaya And Pathyamalakyadi Kasaya In Excessive Menstrual Bleeding

Phase 2
Not yet recruiting
Conditions
Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,
Registration Number
CTRI/2021/02/030961
Lead Sponsor
Parul Institute Of Ayurved
Brief Summary

The process of cyclic menstruation is natural phenomenon. Regular cyclic menstruation results from the relationship between the endometrium and its regulating factors. Menstruation denotes the healthy state of female reproductive system but if the cycle turns to be abnormal with excessive and prolonged bleeding, associated with pain or during intermenstrual period, it is suggestive of some underlying pathology. In modern science asrigdara can be closely co-related with DUB. Dysfunctional uterine bleeding is best defined as abnormal uterine bleeding without any clinically detectable organic, systemic and iatrogenic cause (pelvic pathology i.e tumors, inflammation or pregnancy is excluded). The current line of treatment include medical and surgical methods, plays insignificant role besides the adverse effects. Hormones play a major role in the management of DUB (Asrigdara) but their use for longer period is proved to be dangerous and sometimes induce carcinogenic effect on the genital tract. In view of the problems of the current therapies, need is felt to revalidate certain ayurvedic formulations for the management of asrigdara without adverse effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
40
Inclusion Criteria

Patients fulfilling the diagnostic criteria Patients diagnosed as DUB Both married and unmarried women Patients ready to sign the informed consent form.

Exclusion Criteria

Patients with systemic disorders Patients with IUCD and patients taking OCPs Patients with uterine and pelvic pathology Benign and malignant growth in uterus Endometrial and endocervical polyp Threatened, spontaneous or incomplete abortion Patients having Hb % less than 8 grams.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Beneficial for irregular, prolonged and heavy menses35 days
Secondary Outcome Measures
NameTimeMethod
Also reduce symptoms like angamarda, daurbalya, bhrama, aruchi, daha, trusha etc15 days

Trial Locations

Locations (1)

Parul Ayurved Hospital

🇮🇳

Vadodara, GUJARAT, India

Parul Ayurved Hospital
🇮🇳Vadodara, GUJARAT, India
Dr Rita Makim
Principal investigator
7990727524
ritamakim@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.